By Rishika Sadam
HYDERABAD (Reuters) – Indian vaccine manufacturer Bharat Biotech said on Tuesday its phase 3 trials of an oral cholera vaccine proved that it is safe for public use.
The company, which developed Hillchol under license from Singapore-based Hilleman Laboratories, said it is launching Hillchol with a capacity to produce 200 million doses.
(Reporting by Rishika Sadam; Editing by Varun H K)
Comments